Use of Σ-aminocaproic acid and magnesium in psoriasis therapy

Abstract

Due to the insufficient effectiveness of the existing therapy for psoriasis, the development of new promising ways to treat this widespread chronic relapsing disease is one of the most urgent tasks of practical dermatology. High protease activity, especially in the acute phase of the disease, leads to the disturbance of metabolic regulatory systems, changes protein and nucleic acid metabolism and serves as a trigger mechanism, provoking the manifestation of psoriasis. It becomes obvious that during the progression of dermatosis, proteolysis enzyme inhibitors and medications that help restore the activity of protease inhibitors in the patient's body are justified.

Keywords

Kazan Medical archive

References

[1] Суворов А. П.//Папулезные дерматозы. Псориаз.— Саратов, 1987.

RIGHTS & PERMISSIONS

Eco-Vector